chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse practitioner (N.P.) concerning a female patient who on unspecified dates was vaccinated with 3 doses of GARDASIL (Lot# not reported). The patient had an abnormal pap smear on 20-AUG-2010. The pap smear revealed "Atypical squamous cells of undetermined significance (ASCUS) with HPV". The patient sought unspecified medical attention. At the time of reporting, the patient was not recovered. No further information is available.
Tested positive after testing negative for a week.; Tested positive after testing negative for a week.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 20Jan2021 as dose 1, single (Lot number: EL3247), in right arm, on 10Feb2021 as dose 2, single (Lot number: EM9810), in right arm and on 25Oct2021 as dose 3 (booster), single (Lot number: 30145BA) at the age of 66 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 31Mar2022 as dose 4 (booster), single (Lot number: Q7OH21A), in right arm for covid-19 immunisation. The patient had no relevant medical history (No known allergies). There were no concomitant medications (No other medication in 2weeks). The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Tested positive after testing negative for a week.". Tested positive after testing negative for a week. Mild cold. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Tested positive after testing negative for a week; Negative, notes: Tested positive after testing negative for a week. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Approx 1 week following injection #1 of series, noted a rash/cellulitic area at the injection site. This area has gotten progressively larger over the past 48-72h.
Chronic local pink/red inflamed nodule measuring about 2.5 cm x 2.0 cm at site of inoculation right upper arm over deltoid.
Patient began to feel numbness and tingling in fingers and toes 15 minutes after injection.  Was given water and support.  30 minutes after injection stated her throat was numb, her tongue was tingling and she had a very dry mouth.  BP was  slightly elevated at 133/100.  Pt seemed very anxious and was given emotional support.  Epi was on standby, discussed course with MD and was advised to wait giving epi unless symptoms worsened.  45 mins after injection symptoms were worsening.  Pt able to breath but mouth and throat tingling was worsening.  Called 911 to provide observation in case symptoms worsened.  Pt agreeable to being observed in ED.
One day  after getting 1st covid vaccination vaginal bleeding for 21 days and joint pain. Joint pain has not subsided.
Abnormal blood glucose values in known diabetic for week following administration resulting in DKA.  Known Dx of DM1.  Patient at baseline has variable adherence to insulin therapy.  3/18/09 Received hospital medical records of 11/3-11/5/2008. FINAL DX: DKA resolved Records reveal patient experienced HA, nausea/vomiting x 1 day & increased glucose x 1 week.  Admitted PICU.  Tx w/IVF & insulin.  Patient admitted noncompliance w/diet recently as no evidence of infection.   Returned to ER 11/24/08. FINAL DX: vomiting, hyperglycemia Patient missed evening insulin dose & experienced vomiting, glucose 300, pH 7.28.  Tx w/IVF & insulin.  Improved, meds adjusted & d/c to home w/endocrine clinic f/u.
pt recvd vax 28FEB95 in lt arm; mom stated evening rt arm in deltoid area swelled up w/hives noted on arm which spread to body & then started to fade; mom is a nurse & gave pt DPH; arm swelling went down overnoc; cont to break out in small;
NAUSEA; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) once a total dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of nausea was not reported. This report was non-serious.
30APR92 recvd 1 dose of Engerix-B & 2AUG92 devel tiredness, dizziness, lightheaded, sl fever & diarrhea which lasted about 24 hrs & went away;
Approximately 2 minutes post vaccination with Pfizer Covid-19 shot patient stood to leave and experienced dizziness and nausea.  She then experienced syncope and began to fall to the floor. Her mother and myself were able to catch her and lower her down gently without further injury.  Patient experience loss of consciousness for approximately 1 minute and was quickly awake and aware of her surroundings.  Upon awaking she complained of ringing in her ears, she did not have any shortness of breath or had any visibly signs or symptoms of swelling or redness on her skin.  her skin appeared cool and clammy to the touch.  She remained on the floor for ~10 minutes and was given an ice pack.  She was then assisted into a chair and given some water.  Her blood pressure (100/62) and pulse were taken and were both normal.   Patients mother is a nurse within our health system and was present during the entire encounter.  Pts mom said she was comfortable taking her home and will monitor her and bring her in for further evaluation if she feels necessary.
83-year-old obese male with a past medical history of CKD 3, CAD s/p CABG, diabetes, hypothyroidism, GERD, hypertension with chronic shoulder pain who was on the floor and was not able to get up.  He yelled at a neighbor who came and EMS was called.  He adamantly denies that he fell. He initially said that he lays on the floor because it is more comfortable but then later retracted this.  He says it is part of his routine.  He had difficulty expressing himself of the reason why he lays on the floor.  He said he "could not find the words". In the ED, CT of the head showed no acute intracranial abnormality. Chest x-ray showed blunting including left costophrenic angle possible pleural effusion. Patient had increased
c/o itchiness on neck, arms, legs, about 10 minutes after shots were given, no difficulty breathing, nor swallowing, no rash noted. BENADRYL 25 mg given with itchiness.
Fever ,chills ,headache ,pain in the arm& abdominal  Rash in both arms & around the neck
Patient was transferred to Medical Center ICU on 02/17/2022 for further evaluation of lower GI bleed.  Patient initially presented to Hospital on 01/27/2022 with COVID, patient was started on steroids, remdesivir, baricitinib, broad-spectrum antibiotics, and was intubated on 02/05/2022, and extubated on 02/15/2022.  Patient was placed on a full dose anticoagulation for subsegmental PE diagnosed on 01/30/2022 but repeat CT PE study was negative on 2/9/2022.  Patient started having maroon bowel movement, GI was consulted, and recommended patient transfer to higher level of care.  Upon arrival patients ABG showed PCO2 was in range of 70, normal PH.  Code status was changed to DNR d/t poor prognosis, and ultimately changed to Comfort care.  Patient expired on 03/02/2022.
Abd rash on abdomen starting 1-17-11. Con't to spread to legs, then arms, then back and finally head as of 1-31-11. Seen by MD on 1-25-11. T 102 degrees under arm that day. Double ear infection dx. Private MD thought client possibly has Gianotti Crosti related to vaccines. As of 1-31-11 rash is starting to crust over.
lyme disease (rash and anxiety); high level of aluminium in her blood stream which damaged her mitochondria and thinned the cell walls; bartonella (rash, insomnia and anxiety); high level of aluminium in her blood stream which damaged her mitochondria and thinned the cell walls; high level of aluminium in her blood stream which damaged her mitochondria and thinned the cell walls; This spontaneous report was received from a company representative who read about the event in a non-fiction book. The author spoke about her daughter of an unknown age. The patient's pertinent medical history included irritable bowel syndrome with constipation. Her drug reactions or allergies and concomitant therapy were not reported.  On an unknown date, the patient was vaccinated with a dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, anatomical location, lot# and expiry date were not reported), for prevention of human papillomavirus (HPV).        On an unknown date, the patient experienced rash, insomnia and anxiety. The doctors could not figure out what was wrong with her. On an unknown date, they eventually diagnosed her with Lyme disease and Bartonella. On an unknown date, she had a high level of aluminium in her blood stream which damaged her mitochondria and thinned the cell walls. On unknown dates, the patient had centers for disease control and prevention (CDC) lyme screening test, Western blot test, enzyme-linked immunosorbent assay (ELISA) test, specialized Bartonella test and cellular blood test performed, however no results were provided. On unknown dates, she was treated with amoxicillin, azithromycin, herbs and unspecified intravenous medication for the events. It was unknown, if the patient was hospitalized due to the events. The outcome of the events was unknown. The relatedness between the events and the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was not provided by the reporter, however the author reported the doctors believed the papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccine caused an increase of aluminium in the patient's blood stream.  Upon internal review, the event of Lyme disease and mitochondrial toxicity were considered to be medically significant.
A 46-year-old male, with no illness at the time of vaccination, received a first dose of YF-VAX (Lot number UF30AA; route/site of administration not reported) on 10 July 2008. Two days later, the patient developed severe mid gastric abdominal pain. The patient was evaluated in the emergency room but was not admitted to the hospital. At the time of the report, the patient continued to complain of n, which he descried as right upper quadrant pain. follow up information was received on 11 August 2008 from a health care professional. The patient received a first dose of YF-VAX (Lot number UF340AA) subcutaneously in the left deltoid on 08 July 2008 (previously reported as 10 July 2008). The patient's date of birth was amended to 23 May1962 (previously reported as 23 March 1962). The patient had a ALT value of 171 on 12 July 2008. On 15 July 2008 her ALT value was 100 with a significant decrease in RUQ pain. No other labs were performed. There was no definitive diagnosis made other than abdominal pain. The patient had fully recovered from the events. Follow up information was received on 29 August 2008 from a health care professional. The patient's final diagnosis was abdominal pain with an unknown etiology. There was no treatment provided. The patient dose not have a prior history of abdominal pain. The patient's abdominal pain resolved after one week.
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. Since July 2014 the patients were vaccinated with a dose of improperly stored ROTATEQ orally (dose and lot # were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: Mostly injection site reaction, large yellow bruise( 5.5 cm long and 2.5 wide) at site of injection with clotted blood/dark bruise near immediate areameasuring 11.5 cm long and 6 cm wide, pale-pink radiating ring area surrounding bruise. Also has a nearby knot in area that is throbbing.
First dose induced body aches and soreness as expected, second dose was received at 10am and by 3pm I was having chest pains, body aches and proceeded to stay in bed for 40 hours and then went to the ER and ended up having a heart procedure. Received Angioplasty treatment, stayed in hospital for 2 days.
Information has been received from a medical assistant concerning a 4 year old male who on 07/28/99 was vaccinated SC in the left arm with a first dose of varicella virus vaccine live (Lot # 631066/0446J).  On 06/16/2003 the pt was seen in the physician's office with a red, itching rash on his stomach, legs, under the arms and in the groin area that had started on 06/13/03.  Vesicles were noted on his abdomen and buttocks. The pt was diagnosed with varicella. The pt had vomiting x1 and there was no fever. The pt was treated with colloidal oatmeal bath (Aveeno), calamine lotion and Benadryl. It was unknown if the pt recovered. It was also reported that 3 other pt's were vaccinated with a dose of varicella virus vaccine live and developed varicella (WAES # 0306USA02442, 0306USA02867 & 0306USA02868).  Additional information has been requested.
SLEEP RELATED HYPOVENTILATION OR HYPOXEMIA 12/17/2021 FAILURE TO THRIVE SYNDROME, ADULT CHRONIC NEUROMUSCULAR RESPIRATORY FAILURE 1/21/2022 FAILURE TO THRIVE SYNDROME, ADULT CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/21/2022 FAILURE TO THRIVE SYNDROME, ADULT ACUTE ON CHRONIC RESPIRATORY FAILURE 12/17/2021 FAILURE TO THRIVE SYNDROME, ADULT ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/21/2022 FAILURE TO THRIVE SYNDROME, ADULT RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/2/2022 FAILURE TO THRIVE SYNDROME, ADULT HYPOXIA 12/17/2021 FAILURE TO THRIVE SYNDROME, ADULT SLEEP RELATED HYPOVENTILATION OR HYPOXEMIA 12/17/2021 DYSPNEA CHRONIC NEUROMUSCULAR RESPIRATORY FAILURE 1/21/2022 DYSPNEA CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/21/2022 DYSPNEA ACUTE ON CHRONIC RESPIRATORY FAILURE 12/17/2021 DYSPNEA ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 1/21/2022 DYSPNEA RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/2/2022 DYSPNEA HYPOXIA 12/17/2021 DYSPNEA
developed shingles; rash was unilateral; blistering; This case was reported by a nurse via sales rep and described the occurrence of shingles in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th May 2020, the patient received the 1st dose of Shingrix. On 23rd May 2020, 4 days after receiving Shingrix, the patient experienced shingles, rash and blister. On an unknown date, the outcome of the shingles, rash and blister were unknown.   It was unknown if the reporter considered the shingles, rash and blister to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Shingrix, the patient developed shingles. The rash was unilateral and blistering. This case was linked with case US2020AMR089341, reported by the same reporter.
SLIGHT FATIGUE; MUSCLE ACHES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported, per procedure no follow up will be requested for this case.  No concomitant medications were reported. On 31-MAR-2021, the subject experienced slight fatigue. On 31-MAR-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slight fatigue, and muscle aches on 01-APR-2021. This report was non-serious.
Pt called pharmacy to inform of  a pruritic papular rash (face, arms, and trunk) that had appeared about 3 days after her Abrysvo vaccine.  Pharmacy told her to take 2  benadryl 25mg OTC and call her md Monday morning.
died/cancer; collapsed on the floor; eyes rolled back; stopped breathing for a very short.; This is a spontaneous report from a contactable consumer. A 70-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: en6100, expiry date not reported), via an unspecified route of administration, administered in right arm Right on 06Mar2021 11:00 at a single dose for covid-19 immunization.Medical history included stage 4 esophagis cancer and mushroom allergies (known allergies to mushrooms). The patient had no covid prior vaccination; not diagnosed with COVID-19.  The patient had other medications (unspecified) that the patient received within 2 weeks of vaccination. The most COVID-19 vaccine was administered in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of bnt162b2 (lot number: el9267) for covid-19 immunisation in the right arm on 13Feb2021. The patient was not tested for covid post vaccination. Since the vaccination, the patient has not been tested for COVID-19. On the afternoon of 06Mar2021 (16:00), patient collapsed on the floor, eyes rolled back, stopped breathing for a very short. The patient was revived and carried to bed. She died at 4 am on the 13Mar2021. She told the reporter she did not want to go to the hospital and she said she wanted to die at home. The reporter stated that the cause of death was cancer since an unknown date. The events were reported as serious resulting in death. No treatment received for the adverse events reported. The patient died on 13Mar2021. The causes of death were cancer, collapsed on the floor, eyes rolled back, and stopped breathing for a very short.  An autopsy was not performed.; Reported Cause(s) of Death: collapsed on the floor; eyes rolled back; stopped breathing for a very short; died/cancer
COVID 19 vaccine EUA Tingling on skin along jaw line of face, started 2 hours after vaccine. No rash. Localized. Resolved without treatment within 30 minutes.
Information was received from an office administrator concerning a female patient of unknown age. On 14-FEB-2017, the patient was inadvertently given a dose of PROQUAD (lot #M037012, expiration date 21-FEB-2018; dosage and route of administration not provided) instead of M-M-R II (albumin status and lot number not provided). The administrator was unable to provide a reason why the incorrect vaccine was given. No adverse effect reported. No additional information was provided. 03-MAR-2017: Lot #M037012, albumin status rHA, was verified to be a valid lot number for PROQUAD. Additional information has been requested.
On 5/18/06 patient was administered her third Hep B in her second series of injections.  On 5/19/06 she started with pain in hre arm, collar bone, and neck with fever of 99-100 degrees.  The fever continued off and on up to 103.7 at the highest with heart palpitations and body aches.  She has been evaluated by the MD with a complete work-up being done including an ultrasound of the heart with a 24 hour holter monitor, EKG, chest x-ray, and blood work.  No results have returned to Employee Health to be able to report.
This spontaneous report as received from a other refers to a 61 year old female patient with hypothyroidism, blood cholesterol increased and drug hypersensitivity. On 29-AUG-2017, the patient was vaccinated with PNEUMOVAX 23 lot # N010105, intramuscular for prophylaxis. Concomitant therapies included losartan potassium (COZAAR) and levothyroxine sodium (SYNTHROID). On 29-AUG-2017, 1 day after onset of therapy, the patient experienced injection site erythema, skin warm, injected limb mobility decreased, injection site warmth and injection site swelling.  The outcome of skin warm, injection site warmth, injection site swelling, injection site erythema and injected limb mobility decreased is unknown. Additional information has been requested.; Sender's Comments:  US-009507513-1708USA013312:
Arm became red and hot, started slurring and drooling and found it hard to breathe.
Document Type: US Abdomen Complete Document Subject: US Abdomen Complete Performed By: MD on August 31, 2022 09:56 EDT Verified By: MD on August 31, 2022 10:16 EDT Encounter Info: Hospital, Outpatient, 08/31/22 - 08/31/22  * Final Report *  Reason For Exam screen for splenomegaly  Report EXAMINATION:  US Abdomen Complete  DATE:  08/31/2022 09:56  CLINICAL HISTORY: Abnormal labs.  COMPARISON: 8/25/2008 and 3/4/2008.  DISCUSSION: The pancreas is obscured by overlying bowel gas. The liver is heterogeneously hyperechoic suggesting diffuse fatty infiltration. Small hypoechoic structures in the left lobe appear to represent small cysts. There is focal sparing adjacent to the gallbladder fossa. The gallbladder has a normal appearance without evidence of intraluminal filling defect, wall thickening or pericholecystic fluid. The common bile duct is within normal limits at 0.2 cm diameter. The spleen is enlarged with a length of 16.3 cm. The right and left kidneys measure 12.5 and 10.5 cm in length, respectively. There is cortical scarring in the left kidney. The right kidney has a normal appearance. The abdominal aorta and inferior vena cava are obscured by overlying bowel gas.  IMPRESSION:  Nonvisualization of the pancreas, abdominal aorta and inferior vena cava due to overlying bowel gas.  Diffuse fatty infiltration of the liver. There are small cysts in the left hepatic lobe.  Mild splenomegaly.  Chronic cortical scarring of the left kidney.  Normal appearance of the gallbladder and common bile duct.  Electronically Signed by:  Dictated on: 8/31/2022 10:10 AM    Signature Line This examination and reported findings have been reviewed and confirmed by the undersigned.   Read By:  MD   I authorize my name to be Electronically affixed by using my unique signature access code.   Click VIEW IMAGE icon to Display Image This document has an image